AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2005
Sep 9, 2005
35134_dirs_2005-09-09_beca60f9-3edb-4c77-8082-cc31905f18a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2005-09-09
Reporting Person: C.S. Finance LLC (owned by Gerald L. Jensen)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-09-09 | Croff Preferred B shares | P | 29365 | $3 | Acquired | 357606 | Direct |
Footnotes
F1: This includes 132130 shares held by Jensen Development Company, which is wholly owned by Gerald L. Jensen, the President, CEO, Director and 10% owner of Croff. This also includes 196111 shares held by Gerald L. Jensen, individually. Of this total, 75,050 shares were purchased as part of the Tender Offer and not all of these shares have been delivered to Gerald L. Jensen. CS Finance LLC, the reporting party here, is also wholly owned by Gerald L. Jensen.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 16